Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: Jeffrey Lancet, M.D
Woman and Man Max 99 years
Jeffrey Lancet, M.D
Update Il y a 4 ans
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
The purpose of this study is to determine whether the WT-1 vaccine causes an immune response and is safe. The WT-1 vaccine is made up of protein pieces that the patient's immune system can...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jeffrey Lancet, M.D
Update Il y a 4 ans
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
This study is being done to see how safe an investigational drug is and test how well it will work to help people with refractory/relapsed myelodysplastic syndrome (MDS) or chronic myelomo...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jeffrey Lancet, M.D
Update Il y a 4 ans
Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
The purpose of this study is to: - Test the safety of the research study drug, lenalidomide, when given with Idarubicin and Cytarabine - See how many respond to combinat...
Country
None
organs
None
Specialty
None
Closed trial
More information